APM Stock Summary and Trading Ideas (Aptorum Group Limited - Class A | NASDAQ:APM)

Aptorum Group Ltd clinical-stage biopharmaceutical company. It is engaged in the discovery, development, and commercialization of therapeutic assets to treat diseases with unmet medical needs, particularly in oncology (including orphan oncology indications) and infectious diseases. The company operates in two segments: Therapeutics and Non-Therapeutics. The projects are ALS-4, SACT-1, and RPIDD. It is also engaged in providing healthcare services.

Aptorum Group Limited - Class A trades on the NASDAQ stock market under the symbol APM.

As of October 14, 2024, APM stock price climbed to $1.75 with 16,161 million shares trading.

APM has a market cap of $9.57 million. This is considered a Sub-Micro Cap stock.

In the last 3 years, APM traded as high as $27.20 and as low as $1.35.

The top ETF exchange traded funds that APM belongs to (by Net Assets): ONEQ.

APM has underperformed the market in the last year with a price return of -11.6% while the SPY ETF gained +35.5%. APM has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -56.7% and -5.4%, respectively, while the SPY returned +5.3% and +2.2%, respectively.

APM support price is $1.48 and resistance is $1.89 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that APM shares will trade within this expected range on the day.